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Abstract
This study was performed to investigate the effect of chlorella on cadmium (Cd) toxicity in Cd- administered rats. Sixty male Sprague-Dawley
rats (14 week-old) were blocked into 6 groups. Cadmium chloride was given at levels of 0 or 325 mg (Cd: 0, 160 ppm), and chlorella  powder
at levels of 0, 3 and 5%. Cadmium was accumulated in blood and tissues (liver, kidney and small intestine) in the Cd-exposed groups, while the
accumulation of Cd was decreased in the Cd-exposed chlorella groups. Fecal and urinary Cd excretions were remarkably increased in Cd-exposed
chlorella groups. Thus, cadmium retention ratio and absorption rate were decreased in the Cd exposed chlorella groups. Urinary and serum creatinine,
and creatinine clearance were not changed in experimental animals. In addition, metallothionein (MT) synthesis in tissues was increased by Cd
administration. The Cd-exposed chlorella groups indicated lower MT concentration compared to the Cd-exposed groups. Moreover, glomerular filtration
rate (GFR) was not changed by dietary chlorella and Cd administration. According to the results above, this study could suggest that Cd toxicity
can be alleviated by increasing Cd excretion through feces. Therefore, when exposed to Cd, chlorella is an appropriate source which counteracts 
heavy metal poisoning, to decrease the damage of tissues by decreasing cadmium absorption. 
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Introduction3)
Cadmium (Cd) is one of the heavy metals and existing very 
low levels in nature (Chapman et al., 2003). However, it is very 
toxic and an important environmental pollutant in soil, water, 
air, food and smoke (Järup et al.,  1998). Cadmium is mainly 
used in the industry for coating steel, glass and plastics (including 
polyvinyl chloride), and for nickel cadmium battery production 
(Tsalev & Zaprianov, 1993). It has a very long biological half-life 
(10-30 years) in human body and its toxicity is dependent on 
the route, amount and the duration of exposure (Goering et al., 
1987; Goyer & Cherian, 1995; Satarug et al., 2003). The chronic 
Cd exposure in human appears to result in nephrotoxicity and 
osteoporosis, pulmonary emphysema, liver dysfunction, etceteras 
(Berglund  et al., 2000; Goyer & Cherian, 1995; Rikans & 
Yamano, 2000; Shaikh et al., 1999). When cadmium is taken 
into the body, it is slowly excreted after combining with proteins 
like albumin and metallothionein (MT), or negative ions of other 
molecules, especially the -SH group, without the process of 
metabolism like oxidation, reduction, and alkylation. Also, it is 
severely toxic in cases of both acute and chronic intoxications; 
your liver and testis become the target organs during acute 
intoxication, while your kidney becomes the target organ when 
chronic Cd intoxication happens (Brzóska et al., 2003; Casalino 
et al., 2002). 
Metallothionein (MT) has the molecular weight of 6,000~ 
7,000 and does not contain aromatic amino acids and histidine, 
and it is a low molecular weight protein abundant in cysteine 
(33%) (Kägi & Schäffer, 1988; Manuel et al., 1992). Metallothionein 
has 7 metal binding sites, so it can control the metabolism of 
several metal ions and mitigates toxicity of heavy metals. It also 
relates to the immune reaction and prevents tissue damage caused 
by heavy metal (Nordberg, 1992). The MT synthesis is known 
to be induced by several metal ions and hormones, stress and 
cytokine (Hidalgo et al., 1990). There is a report that MT subsists 
in a very low density under normal circumstances, but the MT 
amount grows when the synthesis is promoted by metals like 
Cd or Pb in organs such as liver (Nordberg & Nordberg, 1987). 
MT can be synthesized anywhere inside the body but mostly 
in the liver and kidney, and can be combined with Cd, which 
prevents free reactive Cd from making to the body which makes 
toxic materials (Cousins et al., 1973). The half-life of MT differs 
to the metal it combines with, but is rather short from 1 to 4 
days, so the MT must be combined endlessly to counteract poison 
made by Cd or heavy metals (Revis & Osborne, 1984). The study 
about Cd and MT synthesis and Cd's removal system through 
MT has been developed profoundly because Cd's affinity with 
MT is high compared to other metal ions. As seen above, the 
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Table 1. Specifications of chlorella powder extract
Components Chlorella powder extract 
(per 100 g powder)
Protein 60.6 g
Carbohydrate 3.7 g
Fat 12.8 g
Dietary Fiber 13.0 g
Ash 4.5 g
Moisture 5.4 g
Calcium 5.1 mg
Vitamin A potency 58,900 IU
Vitamin C  74 mg
Vitamin E  22.8 mg
Total 100 g
Calorie 372 kcal
Table 2. Classification of experimental groups
Groups
1) Dietary Cadmium level
(ppm)
Dietary chlorella level 
% (w/w)
NC0 0 0
NC3 0 3
NC5 0 5
CC0 160 0
CC3 160 3
CC5 160 5
1)  N C 0  :  N o  c a d m i u m  w i t h  0 %  c h l o r e ll a  p o w d e r
N C 3  :  N o  c a d m i u m  w i t h  3 %  c h l o r e ll a  p o w d e r 
N C 5  :  N o  c a d m i u m  w i t h  5 %  c h l o r e ll a  p o w d e r 
C C 0  :  C a d m i u m  ( 1 6 0  p p m )  w i t h  0 %  c h l o r e ll a  p o w d e r 
C C 3  :  C a d m i u m  ( 1 6 0  p p m )  w i t h  3 %  c h l o r e ll a  p o w d e r 
C C 5  :  C a d m i u m  ( 1 6 0  p p m )  w i t h  5 %  c h l o r e ll a  p o w d e r 
Table 3. Composition of experimental diets (g/kg diet)
Group
1)
Ingredients NC0 NC3 NC5 CC0 CC3 CC5
Corn starch 400.49  388.47  380.46  400.16  388.15  380.14 
Dextrinized
cornstarch 132.00 128.04 125.40  132.00  128.04  125.40 
Sucrose 100.00 97.00  95.00  100.00  97.00  95.00 
Casein
(>85% protein) 200.00 194.00 190.00  200.00  194.00  190.00 
Soybean  oil 70.00  67.90  66.50 70.00 67.90 66.50 
Fiber 50.00  48.50  47.50 50.00 48.50 47.50 
Mineral mix
2) 35.00  33.95  33.25 35.00 33.95 33.25 
Vitamin mix
3) 10.00 9.70  9.50  10.00  9.70  9.50 
Choline bitartrate 2.50  2.43  2.38  2.50  2.43  2.38 
TBHQ 0.01 0.01  0.01  0.01  0.01  0.01 
chlorella powder 0 30.00  50.00  0 30.00 50.00 
CdCl2 0 0 0 0.325 0.325 0.325
Total weight 1000 1000 1000 1000 1000 1000
Energy calories (kcal) 3736.4  3735.9  3735.6  3735.2  3734.7  3734.4 
Energy 
ratio
(%)
Carbohydrate 64.0 62.2  61.0  64.0  62.2  61.0 
Protein 19.2 20.5  21.5  19.2  20.5  21.5 
Fat 16.9 17.3  17.6  16.9  17.3  17.6 
1)  See  Table  2.
2) Mineral mix (AIN-93G-MIX) (g/kg mixture) : anhydrous calcium carbonate, 357; 
monobasic potassium phosphate, 196; sodium chloride, 74; potassium sulfate, 
46.6; tripotassium citrate monohydrate, 70.78; magnesium oxide, 24; ferric citrate, 
6.06; zinc carbonate, 1.65; manganous carbonate, 0.63; cupric carbonate, 0.3; 
potassium  iodate,  0.01;  anhydrous  sodium  selenate,  0.01025; 
ammoniumparamolybdate  4-hydrate,  0.00795;  sodium  metasilicate  9-hydrate, 
1.45; chromium potassium sulfate 12-hydrate, 0.275; boric acid, 0.0815; sodium 
fluoride,  0.0635;  nickel  carbonate,  0.0318;  lithium  chloride,  0.0174;  ammonium 
vanadate,  0.0066;  powered  sucrose  221.026
3) Vitamin mix (AIN-93-VX)  (g/㎏  mixture)  :  Niacin  3,  Calcium  Pantothenate  1.60, 
Pyridoxine HCl 0.70, Thiamine HCl 0.60, Riboflavin 0.60, Folic Acid 0.20, Biotin 
0.02,  Vitamin  E  Acetate  (500  IU/g)  15,  Vitamin  B12  (0.1%)  2.50, T h i t a m i n  A 
Palmitate  (500,000  IU/g)  0.80,  Vitamin  D3  (400,000  IU/g)  0.25,  Vitamin 
K1/Dextrose  Mix  (10  mg/g)  7.50,  Sucrose  967.23 
study about the prevention and the treatment of Cd-intoxication 
is becoming a field of interest. While the study about the dietary 
factor which affects absorption of Cd into the body is drawing 
attention, there is a report that protein, calcium, and fiber reduce 
the absorption of Cd and the accumulation to the liver and kidney 
(Omori & Muto, 1977; Revis & Osborne, 1984). 
In addition, chlorella has been demonstrated to develop 
tolerance to Cd polluted environment (Morita et al., 1999). 
Chlorella is a unicellular green algae that reproduces at a rapid 
rate. It has been known to contain highly nutritious substances 
and to exert various biological effects (Kojima et al., 1973). 
Chlorella contains about 55~67% protein, 1~4% chlorophyll, 
9~18% dietary fiber and an amount of minerals and vitamins 
(Morita  et al., 1999). Also, it contains all the essential amino 
acids required for the nutrition of animals and humans. This algae 
is considered to be highly resistant to heavy metals such as Cd. 
The algae can chelate heavy-metal ions such as Cd (Yoshida 
et al., 2006). Recently, chlorella has been used as a health food 
or functional food in Japan, the U.S. and other countries (Morita 
et al., 1999).
In order to use chlorella as a tool for Cd-removal and recovery, 
it is necessary to characterize its metal-tolerance and metal- binding 
capacity. Numerous studies have shown that chlorella intake may 
reduce Cd absorption and accumulation, and also prevent or reduce 
the adverse actions of Cd (Han et al., 2002; Hwang et al., 2006a; 
Hwang et al., 2006b; Morita et al., 1999). The aim of our study 
was to investigate the possible Cd-removal by chlorella intake 
on Cd metabolism. We measured Cd concentrations (blood, urine, 
liver, kidney, small intestine and feces), metallothionein (liver, 
kidney, small intestine) and kidney capacity. 
Materials and Methods
Experimental material
The chlorella powder (chlorella vulgaris) used in this study 
was manufactured by Daesang Co. (Korea) and the characteristics 
of chlorella powder is shown in Table 1.
Animal care and dietary treatment
Sixty 14-week-old male Sprague-Dawley rats (CD (SD)IGS, 
Outbred, Charles River Laboratory Inc. Origin; Jung-Ang Lab 
Animal, Inc., Korea) weighing 399.06 ± 0.8 g were blocked into 
6 groups according to body weight and raised for 10 weeks on 
experimental diets. Two-factorial nested classification design, 
which is shown in Table 2, was used. The independent variables Jee Ae Shim et al. 17
were dietary Cd level and chlorella level. Animals were placed 
in individual stainless steel wire-mesh cages in an automatically 
controlled room. All instruments were treated with 0.4% ethylene 
diamine tetraacetic acid (EDTA) solution, 10% nitric acid 
solution and then washed with distilled water to avoid other 
mineral contaminations.  The composition of the experimental 
diets is shown in Table 3. The chlorella powder (Chlorella 
vulgaris) used in this study was manufactured by Daesang Co. 
(Korea). The diets were mixed according to the AIN-93G diet 
(Reeves  et al., 1993) with slight modifications. Corn starch 
(Daesang Co., Korea) was the only source of carbohydrate in 
the mixture. Casein (Murray Goulburn Co., Australia) was used 
as a source of protein and soybean oil (CJ Co., Korea) was used 
as a source of lipid. Mineral and vitamin mixtures were purchased 
from Dyets Inc. (U.S.A). Also, Cd chloride (CdCl2) was 
substituted for cornstarch and animals were provided with 0.325 
g CdCl2  per kg diet. The 0% chlorella diet contained no chlorella 
in the diet and the 3% chlorella diet contained 3% chlorella per 
kg diet. The 5% chlorella diet contained 5% chlorella per kg 
diet. This study was conducted at the nutrition laboratory of Ewha 
Womans University, in compliance with the Guide for the Care 
and Use of Laboratory Animals. During the experimental period, 
the rats were allowed free access to the experimental diets and 
de-ionized water. Body weight was recorded weekly. Food intake 
was recorded three times per week.
Specimen Collection
To gauge Cd retention ratio, Cd tube feeding was inserted 
of 0.2 ml CdCl2  solution (CdCl2 325 ppm (Cd 160 ppm)) daily 
for the final 2 weeks before the end of the experimental period. 
The rats were not provided with cadmium diet for the tube 
feeding period and considering the stress from tube feeding, 
Cd-free groups had 0.2 ml de-ionized water tube feeding. Feces 
and urine were collected using the metabolic cages for the final 
2 days before the end of the experimental period. Feces were 
weighed and stored at -80℃ until analysis. Urine was collected 
in a bottle treated with a few drops of 0.1% HCl and toluene 
as embalmments. After collection, the bottle was filled up to 
100 ml with de-ionized water and centrifuged at 7,000 rpm for 
10 minutes (Supra 22K high speed centrifuge, Hanil, Korea). 
Aliquots of the samples were stored at -80℃ until analysis. At 
the end of the experimental period, the animals were plundered 
of food for 12 hr and sacrificed after anesthetization with ethyl 
ether. After blood samples were collected directly from the heart 
with a heparinized or non-treated syringe, whole blood samples 
collected with heparin-treated syringes were transferred to 
polypropylene tubes, which were frozen at -80℃ in a deep freezer 
until analysis for cadmium concentration. Blood samples 
collected using non-treated syringes were placed in an ice bath 
for 20 minutes and then centrifuged at 2,800 rpm for 30 minutes 
at 4℃ (Union 55R centrifuge, Hanil, Korea). Obtained serum 
was for measuring the levels of AST and ALT. The liver, kidney, 
spleen, epididymal fat pad, perirenal fat pad and femur were 
removed and weighed. They were cut into small pieces, frozen 
over dry-ice and stored at -80℃ in a deep freezer until analysis. 
AST and ALT
Serum aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) activities were measured using a kit 
(Asan Pharmaceutical, Korea) based on the Reitman-Frankel 
method (Reitman & Frankel, 1957).
Cadmium concentration in blood and urine
Blood and urine cadmium levels were measured from the 
method of Zinterhofer (1971). These were determined using an 
atomic absorption spectrophotometer (AAS, Model 6701F, 
SHIMADU Co., Japan). The analyses were performed at the 
228.8 nm resonance line.
Cadmium concentration in small intestine, liver, kidney and feces
Cd concentrations were measured from the samples using the 
method of Yeager (1971). These were determined using an 
atomic absorption spectrophotometer (AAS, Model 6701F, 
SHIMADU Co., Japan).
Determination of Metallothionein in small intestine, liver and 
kidney
Metallothionein (MT) concentration was measured from the 
method of cadmium/hemoglobin affinity assay (Eaton & Cherian, 
1991; Eaton & Toal, 1982; Onosaka & Cherian, 1982). The rat 
red blood cell (RBC) hemolysate was used from the method of 
Onosaka and Cherian (Yeager et al., 1971). The concentration 
of MT in each tissue was calculated by assuming that 7 g-atom 
of Cd is bound to each mole of thionein which has a molecular 
weight of 6050 by amino acid analysis (Kagi & Nordberg, 1979).
Cadmium retention 
The rates were calculated using the cadmium absorption rate 
and retention ratio. 
Creatinine clearance
Urinary and serum creatinine were measured using a kit 
(IVDLAb CO., LTD, Korea) based on Jaff’s reaction (Owen, 
1954; Simoni et al., 2002). Absorbance at 505 nm was 
determined using a spectrophotometer (Genesys 10 UV, Thermo 
Electron Co., USA). All procedures followed the manufacturers´ 
instructions. These were calculated using  creatinine clearance 
(glomerular filtration rate, GFR, ml/min). 18 Chlorella and Cadmium removal
Table 4. Food intake, calorie intake, weight gain and food efficiency ratio in 
rats fed diets containing chlorella powder
Group
1) Food intake
(g/day)
Calorie intake
(kcal/day)
weight gain
(g/10 weeks)
Food efficiency 
(g/100 kcal)
NC0  25.02 ± 0.68
2)a3)  93.47 ± 2.55
a  182.30 ± 11.37
a  2.82 ± 0.10
a
NC3  24.46 ± 0.57
a  91.40 ± 2.13
a  182.27 ± 5.74
a  2.92 ± 0.04
a
NC5  24.09 ± 0.54
a  89.98 ± 2.01
a  176.47 ± 10.21
a  2.84 ± 0.12
a
CC0  22.90 ± 0.52
ab  85.55 ± 1.95
ab   75.81 ± 3.58
b  1.30 ± 0.08
c
CC3  21.49 ± 0.95
b  80.27 ± 3.53
b   79.33 ± 7.46
b  1.44 ± 0.13
bc
CC5  20.87 ± 0.65
b  77.95 ± 2.42
b   90.27 ± 8.37
b  1.69 ± 0.14
b
1)  See  Table  2.
2)  Mean ± standard  error
3) V a l u e s  w i t h  d i f f e r e n t  a l p h a b e t  w i t h i n  t h e  c o l u m n  a r e  s i g n i f i c a ntly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
Table 5. The weight of liver, kidney and femur in rats fed diets containing 
chlorella powder
Group
1) Liver (g) Kidney (g) Femer (g)
NC0 15.56 ± 0.67
2)a3) 3.00 ± 0.08
a 1.70 ± 0.05
NS4)
NC3 14.12 ± 0.63
a 2.91 ± 0.10
ab 1.63 ± 0.05
NC5 14.23 ± 0.41
a 2.91 ± 0.08
ab 1.86 ± 0.09
CC0 11.73 ± 0.61
b 2.65 ± 0.04
c 1.71 ± 0.05
CC3 11.57 ± 0.34
b 2.72 ± 0.08
bc 1.68 ± 0.13
CC5 11.62 ± 0.34
b 2.72 ± 0.08
bc 1.67 ± 0.04
1)  See  Table  2.
2)  Mean ± standard  error
3) V a l u e s  w i t h  d i f f e r e n t  a l p h a b e t  w i t h i n  t h e  c o l u m n  a r e  s i g n i f i c a ntly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
4)  Values  are  not  significantly  different  among  the  groups  at  α=0.05  using  by 
Duncan’s  multiple  range  test.
Table 6. Serum AST and ALT activities of rats fed diets according to different
Cd levels and dietary chlorella levels (Unit: IU/L)
Group
1) AST (U/L) ALT (U/L)
NC0 50.57 ± 1.79
2)b3) 20.41 ± 1.49
b
NC3 55.81 ± 3.56
ab 22.48 ± 1.91
ab
NC5 54.42 ± 1.58
ab 20.19 ± 1.83
b
CC0 59.78 ± 2.16
a 28.91 ± 2.02
a
CC3 60.43 ± 1.72
a 27.01 ± 3.30
ab
CC5 59.10 ± 2.19
a 25.95 ± 2.03
a
1)  See  Table  2.
2)  Mean ± standard  error
3)  Values  with  different  alphabet  within  the  column  are  significantly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
Table 7. Cadmium concentrations in small intestine, blood, liver, and kidney
Groups
1) Small Intestine
(μg/g wet wt)
Blood
(μg/100 ml)
Liver
(μg/g wet wt)
Kidney
(μg/g wet wt)
NC0  0.17 ± 0.04
c2),3)   0.28 ± 0.03
d   3 . 8 3±0 .4 4
c   4.80 ± 0.46
d
NC3  0.07 ± 0.01
c   0.33 ± 0.03
d   2 . 9 3±0 .3 8
c   4.78 ± 0.70
d
NC5  0.08 ± 0.05
c   0.44 ± 0.05
d   3 . 3 0±0 .4 9
c   2.54 ± 0.40
d
CC0  8.24 ± 1.13
a  36.46 ± 3.45
a  48.51 ± 6.11
a  52.35 ± 6.06
a
CC3  4.05 ± 0.10
b  18.08 ± 3.19
b  31.41 ± 1.18
b  20.50 ± 0.78
b
CC5  3.64 ± 0.76
b  11.74 ± 1.31
c  25.37 ± 4.04
b  13.99 ± 2.17
c
1)  See  Table  2.
2)  Mean ± standard  error
3) V a l u e s  w i t h  d i f f e r e n t  a l p h a b e t  w i t h i n  t h e  c o lu m n  a r e  s ig n if i c a ntly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
Statistical analysis
All results were expressed as means ± standard error (SE). The 
one-way analysis of variance (ANOVA) and mean differences 
among the experimental groups were evaluated by Duncan’s 
multiple range tests at the p<0.05 level. 
Results
Effect of dietary cadmium and chlorella on daily food intake, 
calorie intake, food efficiency ratio in rats
Daily food intake, body weight gain during the experimental 
period and food efficiency consumed are shown in Table 4. Daily 
food intake, body weight gain and food efficiency consumed were 
significantly influenced by the Cd level. The animals fed Cd 
administration diets had significantly lower levels of these 
indexes than animals fed other diets. As shown in Table 4, food 
intake was slightly decreased in chlorella intake groups compared 
with that of 0% chlorella group, and these alterations were shown 
in both Cd-exposed and Cd-free groups. But, food efficiency 
consumed was slightly increased in chlorella intake groups 
compared with that of the 0% chlorella group, especially the 5% 
chlorella diet in Cd-exposed group.
The weight of liver, kidney and femur
The weight of the liver, kidney and femur are shown in Table 
5. In comparison among the chlorella groups, there was no 
significant difference in all these organ weights. The weights of 
the liver and kidney were lowest in rats fed the Cd diet. However, 
these did not show differences among the chlorella groups. Also, 
femur weight had no significant difference in rats fed both Cd 
and chlorella diet.
Serum AST and ALT activities
Serum aspartate aminotransferase (AST) and alanine amino-
transferase (ALT) activities are shown in Table 6. The ranges 
of serum AST and ALT activities were 50.57~60.43 IU/L and 
20.19~28.91 IU/L, respectively. These levels were included 
within the reference range (AST: 39~262 IU/L, ALT: 20~60 
IU/L) in Sprague-Dawley rats (Reitman & Frankel, 1957). 
Therefore all diets were considered to be nontoxic for liver 
function.
Cadmium concentrations in small intestine, blood, liver and 
kidney
Cadmium concentrations in small intestine, blood, liver and 
kidney are shown in Table 7. Cadmium concentrations in blood 
and organ tissues were significantly affected by Cd administration 
and dietary chlorella level. Cadmium concentrations in the blood Jee Ae Shim et al. 19
Table 8. Metallothionein concentrations in small intestine, liver and kidney
Group
1) Small Intestine
(μg/g wet wt)
Liver
(μg/g wet wt)
Kidney
(μg/g wet wt)
NC0 1.39 ± 0.29
d2)3)   5 . 0 4±0 .5 5
c   2.85 ± 0.63
c
NC3 0.97 ± 0.15
d   4 . 9 3±0 .7 0
c  2.97 ± 0.57
c
NC5 0.78 ± 0.11
d   2 . 3 1±0 .5 8
c  2.61 ± 0.28
c
CC0 7.63 ± 0.62
a 723.08 ± 47.63
a 54.32 ± 5.58
a
CC3 5.72 ± 0.43
b 138.74 ± 22.16
b 23.35 ± 3.89
b
CC5 3.61 ± 0.60
c 86.89 ± 13.44
b 18.41 ± 1.73
b
1)  See  Table  2.
2)  Mean ± standard  error
3) V a l u e s  w i t h  d i f f e r e n t  a l p h a b e t  w i t h i n  t h e  c o l u m n  a r e  s i g n i f i c a ntly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
Table 9. Urinary and fecal cadmium excretions, Cadmium retention ratio and 
absorption rate
Group
1) Urinary Cd
(μg/day)
Fecal Cd
(μg/day)
Cadmium 
retention ratio 
(%)
Cadmium
absorption
rate (%)
NC0  2.03 ± 0.53
c2)3)  17.09 ± 1.81
c  N.D
4) N.D
NC3  7.32 ± 1.53
c  20.43 ± 3.02
c N.D N.D
NC5  5.93 ± 0.72
c   8.04 ± 1.33
c N.D N.D
CC0 22.27 ± 3.43
c 199.29 ± 28.85
b  86.52 ± 2.47
a  90.03 ± 1.44
a
CC3 68.34 ± 6.37
b 554.33 ± 56.44
a  65.66 ± 3.91
b  72.28 ± 2.82
b
CC5 95.96 ± 17.72
a 484.72 ± 29.08
a  71.23 ± 1.96
b  75.77 ± 1.45
b
1)  See  Table  2.
2)  Mean ± standard  error
3) V a l u e s  w i t h  d i f f e r e n t  a l p h a b e t  w i t h i n  t h e  c o l u m n  a r e  s i g n i f i c a ntly  different  at 
α=0.05  by  Duncan’s  multiple  range  test.
4)  N.D;  not  detected
Table 10. Urinary creatinine excretions, serum creatinine concentration and 
creatinine clearance
Group
1) Urinary creatinine
(mg/day)
Serum creatinine
(mg/100 ml)
Creatinine clearance
(G.F.R, ml/min)
NC0 22.50 ± 5.53
NS2) 3.70 ± 0.37
NS 0.45 ± 0.12
NS
NC3 27.20 ± 6.62 3.35 ± 0.32 0.64 ± 0.19
NC5 28.00 ± 7.17 3.41 ± 0.42 0.67 ± 0.18
CC0 20.37 ± 4.53 4.54 ± 1.04 0.38 ± 0.11
CC3 23.00 ± 5.17 3.55 ± 0.43 0.53 ± 0.15
CC5 26.26 ± 6.98 3.20 ± 0.42 0.73 ± 0.19
1)  See  Table  2.
2)  Values  are  not  significantly  different  among  the  groups  at  α=0.05  using  by 
Duncan’s  multiple  range  test.
and organ tissues of Cd-exposed groups were significantly higher 
than those of Cd-free groups. However, chlorella intake 
significantly decreased Cd concentrations in the blood and 
kidney, especially animals fed 5% chlorella diet. 
Metallothionein in small intestine, liver and kidney
Metallothionein, consisted with cysteine, exists at a very low 
concentration in general environment (Manuel et al., 1992; Revis 
& Osborne, 1984; Tsuritani et al., 1992). Metallothionein 
concentrations in small intestine, liver and kidney are shown in 
Table 8. Hepatic MT concentration was markedly increased by 
Cd administration compared with that of control groups. 
Specially, this study reveals that MT concentration is significantly 
decreased with chlorella treatment in Cd-exposed groups. In 
addition, renal MT concentration in Cd-exposed groups was 
elevated. Moreover, MT concentration in small intestine was 
higher in Cd-exposed groups than Cd-free groups. When animals 
were administered cadmium, MT concentration in kidney was 
remarkably lower in the 5% chlorella group than the 0% chlorella 
group. These significantly decreased dietary chlorella in a 
dose-dependent manner. There was a relationship between 
Cd-administration and dietary chlorella level in the liver, kidney 
and small intestine.
Urinary and fecal cadmium excretions, Cadmium retention ratio 
and Cadmium absorption rate
The results of cadmium excretions in urine and feces that were 
collected during the administration of cadmium through tube 
feeding and the cadmium retention ratio were showed in Table 
9. Urinary and fecal cadmium excretions of Cd-exposed animals 
were remarkably higher than those of Cd-free animals. However, 
these were decreased with increasing dietary chlorella levels, 
particularly animals fed 5% chlorella diet in urinary cadmium 
excretion. Moreover, Cd excretions in urine and feces were 
affected by the interaction between dietary chlorella level and 
Cd level.
The calculated Cd retention ratio using urinary and fecal Cd 
excretions was significantly affected by dietary chlorella levels. 
Namely, Cd retention ratio of rats fed 3% chlorella diet and Cd 
had the lowest among Cd-exposed groups. But, there was no 
significant difference among Cd-free groups. In addition, 
calculated Cd absorption rate using fecal cadmium excretions 
similarly indicated the results of Cd retention ratio.
Renal creatinine clearance
To estimate abnormalities of renal function by Cd toxicity, 
creatinine clearance was calculated from serum creatinine 
concentration and urinary creatinine excretion. As shown in Table 
10, serum and urinary creatinine, and creatinine clearance were 
not changed in experimental animals.
Discussion
This study investigated the effect of exposure to Cd and the 
influence of chlorella intake on Cd administration. Small 
intestinal absorption of Cd is characterized by high accumulation 
within the intestinal mucosa and metal-binding proteins were 
induced in the presence of Cd. Cd-MT form is excreted into 
the feces with a cell turnover at the same time (Elsenhans et 
al., 1997). After Cd is absorbed from the small intestine into 
blood plasma, Cd is mainly taken up into the liver. The 
Cd-albumin is moved to the liver and Cd-MT form is moved 20 Chlorella and Cadmium removal
to the kidney (Wang et al., 1993). Chronic Cd exposure can cause 
renal proximal tubular dysfunction resulting from the release of 
liver Cd-MT and its accumulation and degradation in the renal 
tubular epithelial cells (Friberg et al., 1974). Therefore, renal 
Cd is made up of free ion form. The reason for this redistribution 
of Cd has been shown to be its binding to MT that it is readily 
filtered through the glomerular membrane and is obtained 
selectively in the renal tubules (Nordberg et al., 1975). Moreover, 
Cd ion induces new renal MT synthesis (Dorian et al., 1992). 
When much amount of Cd-MT existed in the kidney, Cd-MT 
in blood was excreted into urine (Friberg, 1984). A damage of 
the proximal renal tubular cells increases urinary Cd excretion 
with low molecular weight proteins. Also, Cd increases bone Ca 
resorption and is accumulated in bone matrix instead of Ca. From 
the above explanation, Cd affects bone matrix formation and 
mineralization. Thus, it inhibits growth and maturation of bone 
tissue. (Wilson et al., 1996) During the experimental period, a 
decrease in body weight was noted in Cd-exposed groups. 
Consistent with these results, another study (Jemai et al., 2007)
 
showed that body weight gain in the Cd-exposed rats was 
decreased significantly. Also, in numerous other studies (Cousins 
et al., 1973; Toraason & Foulkes, 1984), food intake and food 
efficiency were significantly depressed in Cd-exposed groups 
compared to Cd-free groups. In this study, food efficiency was 
influenced by 5% chlorella diet compared with 0% chlorella diet 
in rats administered Cd. Chlorella contains CGF (chlorella growth 
factor) which is water soluble S-nucleotide adenosyl peptide 
complex and a factor of rejuvenescence. In addition, it helps 
growth promotion of animal and plant, increase of immune 
system and improvement of apoplexy (Han et al., 2002). Thus 
chlorella might prevent growth inhibition of Cd because of CGF 
(chlorella growth factor) which is contained in chlorella. In our 
study, weight of the liver and kidney, which have been known 
to be responsible for Cd removal (Toraason & Foulkes, 1984) 
were decreased by Cd administration, however, these were not 
influenced by dietary chlorella level. The results of our 
experiments could be shown in tissue damage or decrease of 
body weight by Cd-administration, but that were not affected 
by chlorella groups. In addition, the weight of femur was not 
influenced by Cd and dietary chlorella. Femur was affected by 
exposure to Cd in a dose- and duration-dependent manner 
(Brzóska et al., 2005). Finally, rats fed 160 ppm Cd for 10 weeks 
did not induce intoxication in this study, where Cd concentration 
in small intestine was decreased in Cd- exposed chlorella groups. 
Also, fecal Cd excretion was remarkably increased in Cd-exposed 
chlorella groups compared to the Cd-free groups but there was 
no difference among the chlorella groups. Dietary fibers 
contained in chlorella cells may inhibit Cd absorption from the 
digestive tract by promoting its excretion into feces (Singh et 
al., 1999). Dietary fiber could trap Cd within the epithelial cells 
of the intestine and eventually excreted via feces with the 
esquamating cells (Andersen et al., 1992; Valberg et al., 1976). 
In addition, intestinal Cd and MT concentrations were lower than 
the liver and kidney by chlorella in this study. The other study 
reported that after rats were pretreated with Zn, animals once 
injected Cd. The result showed that intestinal Cd concentration 
was elevated after 4 h. but intestinal Cd concentration was 
decreased within 16~24 h. In consequence, the Cd-MT form in 
the small intestine was excreted into lumen after sequestering 
with intestinal lumen cell (Min et al., 1991). Considering these 
facts, the chlorella diet had the effect of Cd-removal by the 
inhibition of intestinal Cd absorption, due to dietary fiber 
contained in chlorella. Therefore, the Cd absorption rate and Cd 
retention ratio were decreased in chlorella diet groups. Cadmium 
concentrations of liver and kidney were increased in Cd-exposed 
groups compared to Cd-free groups in this study. In addition, 
the exposure to Cd increased its concentration in the blood. 
However, Cd concentrations in liver, kidney and blood were 
decreased in Cd-exposed chlorella groups. Hwang et al. (2006a) 
showed that hepatic and renal Cd concentrations were 
significantly decreased in chlorella supplementation groups. 
Thus, it was speculated that chlorella intake decreased Cd 
concentrations in liver, kidney and blood. In mammals, most of 
the total body burden of Cd is associated with MT. One molecule 
of MT can bind with 7 atoms of Zn or Cd. Metallothinein has 
been proposed to play important roles in the removal of heavy 
metals such as Cd
  and in the scavenging of oxygen-free radicals 
(Goering et al., 1995; Sato & Bremner, 1993). Cadmium in the 
cell is classified into two forms; MT-bound form and 
non-MT-bound form. Also, several studies reported that the 
MT-bound form is not toxic. However, the non-MT-bound form 
is having toxicity
  (Manuel  et al., 1992; Nordberg, 1984). A 
non-MT bound form is produced when MT is not synthesized 
yet or when Cd, more than the inducible MT amounts, is inserted. 
Therefore, Cd concentrations in tissues did not reflect in all Cd 
toxicity. Shim et al., showed that hepatic MT II was more 
expressed in the Cd-5C and Cd-10C groups than in the Cd-0C 
group (Shim et al., 2008). In other words, Cd concentration is 
associated with MT synthesis. In fact, the basal MT level in the 
liver and kidney plays an important role in removal of Cd 
toxicity. The amount of synthesized MT in the liver and kidney 
of Cd-administered groups was significantly higher than those 
of Cd-free groups in this study. Absorbed Cd in human body 
induced MT synthesis in accordance with Cd dosage and duration 
of Cd feeding (Park et al., 1994). Other studies showed that MT 
synthesis was increased in proportion to Cd accumulation in the 
body (Goering & Klaassen, 1984; Hwang et al., 2006b). 
Furthermore, it has been reported that Cd induces the 
upregulation of cytoprotective and metal-scavenging proteins 
such as MT (Thevenod, 2003; Thijssen et al., 2007). In addition, 
newly synthesized MT was not induced by chlorella intake in 
this study. Conversely, the chlorella diet was not effective in 
increasing the basal MT level when the Cd was taken up. Also, 
in the other study, 46 male SD rats were given dietary 
supplementation with 1%, 5%, and 10% dried chlorella and 40 
ppm of Cd for 4 weeks. The result showed that total MT synthesis Jee Ae Shim et al. 21
in the liver and kidney was lower in the group of rats on the 
supplementation with chlorella and 40 ppm of Cd than the control 
group of rats on the supplementation without chlorella (Hwang 
et al., 2006a). This result is conflicted with the other study which 
reported that capacity of Cd-MT synthesis to remove Cd was 
increased by chlorella vulgaris (Friberg, 1984). Therefore, this 
may be due to an inhibition of Cd absorption by chlorella in 
the small intestine, resulting in declines in MT synthesis. In this 
study, urinary Cd excretions were increased in Cd exposed 
chlorella groups. Although the accurate mechanism related to this 
result was unknown. Based on the evidence that urinary and fecal 
Cd in Itai-Itai disease is excreted by chlorella intake (Hagino 
& Ichimura, 1975), it is thought that excretion of Cd through 
urine is one of the important ways of Cd removal. Thus, chlorella 
intake could be predicted elimination effect of Cd in human body. 
Urinary and serum creatinine concentrations in Cd-exposed 
groups were not changed compared to those in Cd-free groups 
in this study. However, these concentrations were slightly 
influenced by dietary chlorella. Renal glomerulus was not 
affected by Cd and dietary chlorella intake, and glomerular 
filtration rate (GFR) was not different among experimental 
groups. Therefore, it seems that Cd exposure did not exert severe 
renal toxicity. In summary, fecal and urinary excretions for Cd 
were remarkably increased in the Cd-exposed chlorella groups 
than in controls. Thus, Cd concentrations in tissues and blood 
were decreased in the Cd-exposed chlorella groups and thereby 
MT concentrations in organ tissues were reduced by chlorella 
supplementation in a dose-dependent manner. According to the 
results above, this study could suggest that chlorella inhibited 
Cd absorption, promoting the excretion of Cd from the body 
into feces. Also, it seems that small amount of MT was 
synthesized in this study due to decreased Cd absorption in the 
small intestine.
Literature cited
Andersen O, Nielsen JB & Nordberg GF (1992). Factors affecting 
the intestinal uptake of cadmium from the diet. IARC Sci Publ 
118:173-187.
Berglund M, Akesson A, Bjellerup P & Vahter A (2000). Metal-bone 
interaction.  Toxicol Lett 113:219-225. 
Brzóska MM, Kamiński M, Supernak-Bobko D, Zwierz K & 
Moniuszko-Jakoniuk J (2003). Changes in the structure and 
function of the kidney of rats chronically exposed to cadmium. I. 
Biochemical and histopathological studies. Arch Toxicol 77:344- 
352. 
Brzóska MM, Majewska K & Moniuszko-Jakoniuk J (2005). 
Weakness in the mechanical properties of the femurs of growing 
female rats exposed to cadmium. Arch Toxicol 79:519-530.
Casalino E, Calzaretti G, Sblano C & Landriscina C (2002). Molecular 
inhibitory mechanisms of antioxidant enzymes in rat liver and 
kidney by cadmium. Toxicology  179:37-50. 
Chapman PM, Wang F, Janssen CR, Goulet RR & Kamunde CN 
(2003). Conducting ecological risk assessments of inorganic metals 
and metalloids: Current status.  Human and Ecological Risk 
Assessment  9:641-697.
Cousins RJ, barber AK & Trout JR (1973). Cadmium toxicity in 
growing swine. J Nutr 103:964-972. 
Dorian C, Gatto VH, Gattone 2 & Klaassen CD (1992). Accumulation 
and degradation of protein moiety of CdMT in the mouse kidney. 
Toxicol Appl Pharmacol 117:242-248.
Eaton DL & Cherian MG (1991). Determination of metallothionein 
in tissues by cadmium-hemoglobin affinity assay. Methods 
Enzymol  205:83-88. 
Eaton DL & Toal BF (1982). Evaluation of the Cd/hemoglobin 
affinity assay for the rapid determination of metallothionein in 
biological tissues. Toxicol Appl Pharmacol 66:134-142.
Elsenhans B, Strugala GJ & Schäfer SG (1997). Small-intestinal 
absorption of cadmium and the significance of mucosal metallothionein. 
Hum Exp Toxicol 16:429-434.
Friberg L (1984). Cadmium and the kidney. Environ Health Perspect 
54:1-11.
Friberg L, Piscator M, Nordberg GF & Kjellstrom T (1974). Cadmium 
in the environment. 2nd ed. p.19, CRC Press, OH, Cleveland. USA
Goering PL, Mistry P & Fowler BA (1987). Mechanism of metal 
induced cell injury. In: Haley TJ, Berndt WO (Eds.), Handbook 
of Toxicology, p.384-425. Springer press, Washington DC. USA
Goering PL, Wıuıs MP & Klaassen CD (1995). Toxicology of 
cadmium. (Handbook of Experimental Pharmacology) In: Goyer 
RA, Cherian MG (Eds.), Toxicology of Metals: Biochemical 
Aspects. 115:189-213. Springer-Verlag press, NY. USA
Goering PT & Klaassen CD (1984). Tolerance to cadmium-induced 
hepatotoxicity following cadmium pretreatment. Toxicol Appl 
Pharmacol  74:308-313.
Goyer RA & Cherian MG (1995). Renal effects of metals. In: Goyer 
RA, Klaassen CD, Waalkes MP (Eds.), Metal Toxicology, 
p.389-412. Academic Press, San Diego. USA
Hagino N & Ichimura S (1975). Effect of chlorella on fecal and 
urinary cadmium excretion in “Itai-itai” disease. Nippon Eiseigaku 
Zasshi 30:77.
Han JG, Kang GG, Kim JK & Kim SH (2002). The present status 
and future of Chlorella. Food Science Industry 6:64-69.
Hidalgo J, Garvey JS & Armario A (1990). On the metallothionein, 
glutathione and cysteinee relationship in rat liver. J Pharmacol Exp 
Ther 255:554-564. 
Hwang YK, Choi HJ NM, Yoo JD & Kim YH (2006a). Effect of 
Chlorella on Metallothionein Synthesis and Binding Capacity of 
Cadmium in Cadmium Poisoned Rat Liver and Kidney. J Biomed 
Sci  12:23-27.
Hwang YK, Lee YK, Yun JY, Hwang JM & Yoo JD (2006b). Effect 
of Chlorella on Metallothionein Synthesis and Binding Capacity 
of Cadmium in Cadmium Poisoned Rat Liver and Kidney. J 
Biomed Lab Sci 12:23-27.
Järup L, Berglund M, Elinder CG, Nordberg G & Vahter M (1998). 
Health effects of cadmium exposure―a review of the literature 
and a risk estimate. Scand J Work Environ Health 24:1-51. 
Jemai H, Messaoudi I, Chaouch A & Kerkeni A (2007). Protective 
effect of zinc supplementation on blood antioxidant defense system 
in rats exposed to cadmium. J Trace Elem Med Biol 21:269-273.
Kägi JH & Schäffer A (1988). Biochemistry of metallothionein. 
Biochemistry  27:8509-8515. 
Kagi JR & Nordberg M (1979). In Metallothionein, Birkhauser Verlag. 
p.56-65. Basel press, Boston. USA
Kojima M, Shishido K, Kobayashi S, Dobashi M & Ino S (1973). 22 Chlorella and Cadmium removal
A Chlorella polysaccharide as a factor stimulating RES activity. 
J Reticuloendothel Soc 14:192-208. 
Manuel Y, Thomas Y & Pellegrini O (1992). Metallothionein and 
tissue damage. IARC Sci Publ 118:231-237. 
Min KS, Fujita Y, Onosaka S & Tanaka K (1991). Role of intestinal 
metallothionein in absorption and distribution of orally administered 
cadmium.  Toxicol Appl Pharmacol 109:7-16. 
Morita K, Matsueda T, Iida T & Hasegawa T (1999). Chlorella 
Accelerates Dioxin Excretion in Rats. J Nutr 129:1731-1736. 
Nordberg GF (1992). Application of the ‘critical concentration’ concept 
to human risk assessment for cadmium. IARC Sci Publ 118:3-14. 
Nordberg GF, Goyer R & Nordberg M (1975). Comparative toxicity 
of cadmium-metallothionein and cadmium chloride on mouse 
kidney.  Arch Pathol 99:192-197.
Nordberg M (1984). General aspects of cadmium: transtport, uptake 
and metabolism by the kidney. Environ Health Perspect 54:13-20. 
Nordberg M & Nordberg GF (1987). On the role of metallothionein 
in cadmium induced renal toxicity. Experientia Suppl 52:669-675. 
Omori M & Muto Y (1977). Effects of dietary protein, calcium, 
phosphorus and fiber on renal accumulation of exogenous 
cadmium in young rats. J Nutr Sci Vitaminol 23:361-373. 
Onosaka S & Cherian MG (1982). Comparison of metallothionein 
determination by polarographic and cadmium-saturation methods. 
Toxicol Appl Pharmacol 63:270-274. 
Owen JK (1954). The determination of creatinine in plasma or serum 
or urine: A critical examination. Biochem J 58:4261-4268. 
Park JD, Choi BS, Hong YP & Chang IW (1994). Time-dependent 
pattern of cadmium (Total-, MT bound- and free-) distribution in 
liver and kidney. Chung-Ang Journal of Medicine 19:279-291. 
Reeves PG, Nielsen FH & Fahey GC (1993). AIN-93 purified diets 
for laboratory rodents: final report of the American Institute of 
Nutrition ad hoc writing committee on the reformulation of the 
AIN-76A rodent diet. J Nutr 123:1939-1951. 
Reitman S & Frankel S (1957). A colorimetric method for the 
determination of serum glutamic oxalacetic and glutamic pyruvic 
transaminases.  Am J Clin Pathol 28:56-63. 
Revis NW & Osborne TR (1984). Dietary protein effects on cadmium 
and metallothionein accumulation in the liver and kidney of rats. 
Environ Health Perspect 54:83-91. 
Rikans LE & Yamano T (2000). Mechanisms of cadmium mediated 
acute hepatotoxicity. J Biochem Mol Toxicol 14:110-117. 
Satarug S, Baker JR, Urbenjapol S, Haswell-Elkins M, Reilly PE, 
Williams DJ & Moore MR (2003). A global perspective on 
cadmium pollution and toxicity in non-occupationally exposed 
population.  Toxicol Lett 137:65-83. 
Sato M & Bremner I (1993). Oxygen free radicals and metallothionein. 
Free Radic Biol Med 14: 325-337. 
Shaikh ZA, Zaman K, Tang W & Vu T (1999). Treatment of chronic 
cadmium nephrotoxicity by N-acetyl cysteinee. Toxicol Lett 
104:137-142. 
Shim JY, Shin HS, Han JG, Park HS, Lim BL, Chung KW & Om 
AS (2008). Protective effects of Chlorella vulgaris on liver toxicity 
in cadmium-administered rats. J Med Food 11:479-85.
Simoni RD, Hill RL & Vaughn M (2002). A system of blood analysis. 
J Biol Chem 17:277 
Singh A, Singh SP & Bamezai R (1999). Inhibitory potential of 
Chlorella vulgaris (E-25) on mouse skin papillomagenesis and 
xenobiotic detoxication system. Anticancer Res 19:1887-1891. 
Thévenod F (2003). Nephrotoxicity and the proximal tubule. insights 
from cadmium. Nephron Physiol 93:87-93. 
Thijssen S, Cuypers A, Maringwa J, Smeets K, Horemans N, Lambrichts 
I & Van Kerkhove E (2007). Low cadmium exposure triggers a 
biphasic oxidative stress response in mice kidneys. Toxicology 
236:29-41. 
Toraason M & Foulkes EC (1984). Interaction between calcium and 
cadmium in the 1, 25-dihydroxyvitamin D3 stimulated rat duodenum. 
Toxicol Appl Pharmacol 75:98-104. 
Tsalev DL & Zaprianov ZK (1993). Atomic Absorption Spectrometry 
in Occupational and Environmental Health Practice, p.105-112. 
CRC Press, Boca Raton, FL. USA
Tsuritani I, Honda R, Ishizaki M, Yamada Y, Kido T & Nogawa K 
(1992). Impairment of vitamin D metabolism due to environmental 
cadmium exposure, and possible relevance to sex-related differences 
in vulnerability to the bone damage. J Toxicol Environ Health 
37:519-533.
Valberg LS, Sorbie J & Hamilton DL (1976). Gastrointestinal metabolism 
of cadmium in experimental iron deficiency. Am J Physiol 
231:462-467. 
Wang XP, Chan HM, Goyer RA & Cherian MG (1993). Nephrotoxicity 
of repeated injections of cadmium-metallothionein in rats. Toxicol 
Appl  Pharmacol  119:11-16.
Wilson AK, Cerny EA, Smith BD, Wagh A & Bhattacharyya MH 
(1996). Effects of cadmium on osteoclast formation and activity 
in vitro. Toxicol Appl Pharmacol 140:451-460.
Yeager DW, Cholak J & Henderson EW (1971). Determination of 
lead in biological and related material by atomic absorption 
spectrophotometry.  Environ Sci Technol 5:1020. 
Yoshida N, Ikeda R & Okuno T (2006). Identification and characterization 
of heavy metal-resistant unicellular alga isolated from soil and its 
potential for phytoremediation. Bioresour Technol 97:1843-1849. 
Zinterhofer LJ, Jatlow PI & Fappiano A (1971). Atomic absorption 
determination of lead in blood and urine in the presence of EDTA. 
J Lab Clin Med 78:664-674.